Elizabeth Thurgar tells us about her ISPOR poster reviewing fast-track appraisals at NICE and the evolution of cost comparison
Read More
Olivia Dickinson tells us about her research reviewing oncology submissions to NICE to see how often QoL data is accepted.
The Mtech Access team reflect on a energising and inspiring ISPOR Europe – with commentary from top 10 influencer Prof Phil Richardson
Hannah Baker (Health Economics Consultant) tells us about joining Mtech Access to gain experience with wider market access services
We are delighted to announce that we will be exhibiting at ISPOR Europe from 7th–9th November 2022 in Vienna, Austria. ISPOR Europe is probably the most anticipated HEOR conference of...
Read More
Patient-centric design, ingenuity and a resilient drive to get new technologies to market were all on display at Medtech Innovation Expo. On 8th–9th June 2022 Calum Jones, Lily Westbrook and...
Read More
At Mtech Access we create bespoke digital value communication tools to support our Pharma and Medtech clients’ market access and customer engagement strategies. Here we answer some of the questions...
Read More
Our experts in health economics, value communication, design and digital discussed how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams...
Read More
The National Institute for Health and Care Excellence (NICE) has published updated manuals for methods, processes and topic selection for Health Technology Assessments (HTA). This includes changes to how NICE...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
